Fulgent Genetics (FLGT) Revenue (2015 - 2026)

Fulgent Genetics (FLGT) has 12 years of Revenue data on file, last reported at $71.1 million in Q1 2026.

• Quarterly Revenue fell 3.16% year-over-year to $71.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $237.4 million (down 18.82% YoY) and the FY2025 annual result came in at $322.7 million, up 13.83% from the prior year.
• Revenue grew to $71.1 million in Q1 2026 per FLGT's latest filing, from $400000.0 in the prior quarter.
• The five-year high for Revenue was $320.3 million in Q1 2022, with the low at $400000.0 in Q4 2025.
• Average Revenue over 5 years is $89.7 million, with a median of $72.6 million recorded in 2024.
• The widest YoY moves for Revenue: up 17.18% in 2025, down 99.48% in 2025.
• Fulgent Genetics' Revenue stood at $105.7 million in 2022, then sank by 33.27% to $70.5 million in 2023, then advanced by 8.1% to $76.2 million in 2024, then sank by 99.48% to $400000.0 in 2025, then soared by 17684.5% to $71.1 million in 2026.
• Business Quant data shows FLGT's Revenue at $71.1 million in Q1 2026, $400000.0 in Q4 2025, and $84.1 million in Q3 2025.